Answers are grounded in this paper and cite their sources.
Case report reveals unusual CD34+ micromegakaryocytes and giant platelets in myelodysplastic syndrome, suggesting potential treatment implications.
Myelodysplastic syndromes (MDS) are a group of hematopoietic disorders characterized by ineffective hematopoiesis, with manifestations of cytopenias in one, two, or three lineages. CD34+ micromegakaryocytes and giant platelets are very rarely seen in MDS patients but may lead to unnecessary treatments. Therefore, we report and follow up on an MDS case with such an unusual finding.
No takes yet. Share an insight, caveat, or question.
Hongbo Yu (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: